1-benzylimidazole
inhibits human thromboxane synthetase
Also Known As:
N-benzylimidazole
Networked: 11
relevant articles (1 outcomes,
1 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Seizures (Absence Seizure)
|
2. | Ischemia
|
3. | Neoplasms (Cancer)
08/05/2023
- " Compound 3 bearing 1-benzylimidazole was the most active in both cell lines with IC50 values of 1.26 ± 0.11 and 2.21 ± 0.26 μM, respectively, being also slightly selective against the cancer cells (vs. MRC5 normal human embryonic fibroblast cell lines). " 08/01/1978
- " Quercetin and 1-benzylimidazole also inhibited BP skin tumor-initiating activity. " 08/01/1978
- " The skin tumor-initiating activities of benzo[a]pyrene (BP), 6-hydroxymethylbenzo[a]pyrene (6-OH-CH2-BP), and 6-methylbenzo[a]pyrene (6-CH3-BP), as well as the effects of 7,8-benzoflavone (7,8-BF), quercetin, and 1-benzylimidazole on their activity, were determined in outbred female CD-1 mice by use of a two stage system of tumorigenesis. "
|
4. | Hemorrhage
|
5. | Carcinogenesis
|
|
Related Drugs and Biologics
Related Therapies and Procedures